Libyan International Medical University Journal

: 2021  |  Volume : 6  |  Issue : 1  |  Page : 19--26

Knowledge, attitude, and practice of sudanese pharmacists toward COVID-19 in Khartoum State, Sudan: An online-based cross-sectional study

Safaa Badi1, Abdalrahman B Hamed2, Mohammed S Abualama1, Mohammed A Mustafa1, Muhammad Abdou Abdulraheem1, Bashir Alsiddig Yousef3,  
1 Department of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, Sudan
2 Department of Pharmacology, Faculty of Medicine, Omdurman Islamic University, Khartoum, Sudan
3 Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan

Correspondence Address:
Bashir Alsiddig Yousef
Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Al-Qasr Ave, Khartoum 11111


Background: COVID-19 disease became an outbreak declared by the WHO as a public health emergency that is explicitly threatening the globe. Measures must be taken to control it, and health-care workers' situations need to be assessed. Objectives: The study aimed to assess the knowledge, attitude, and practice of Sudanese pharmacists regarding COVID-19. Materials and Methods: The study was an online descriptive cross-sectional survey, conducted from April to June 2020, among the registered pharmacists in Khartoum, Sudan. Three hundred fifty registered pharmacists were asked to participate in this study, all of them were responded. An online standardized questionnaire was conducted, and data were collected by a convenience sampling method and analyzed using the Statistical Package for the Social Science. Descriptive and inferential statistics were performed. Results: Response rate was 100%, 65,7% of the participants were females. The median age was 27 years, 72.9% of the pharmacists were bachelor degree holders, and 73.1% of participants were community pharmacists. The years of experience were 1–5 years for 54.4% of them. About 69.4% of the participants had sufficient knowledge about COVID-19, 27.1% reported a positive attitude, and 62.6% reported a fair attitude. Moreover, 88.3% of them were wearing facemask, gloves, and frequently use sensitizers. Nearly 47.7% stated that they would not dispense any treatment of COVID-19 without a prescription. Tests revealed that knowledge was statistically significant with gender (P = 0.001) and attitude with age and years of experience (P = 0.039, 0.01), respectively. Conclusions: More than two-third of the participants have sufficient knowledge regarding COVID-19. Only one-tenth of them have a negative attitude, and their practice toward the disease was relatively good.

How to cite this article:
Badi S, Hamed AB, Abualama MS, Mustafa MA, Abdulraheem MA, Yousef BA. Knowledge, attitude, and practice of sudanese pharmacists toward COVID-19 in Khartoum State, Sudan: An online-based cross-sectional study.Libyan Int Med Univ J 2021;6:19-26

How to cite this URL:
Badi S, Hamed AB, Abualama MS, Mustafa MA, Abdulraheem MA, Yousef BA. Knowledge, attitude, and practice of sudanese pharmacists toward COVID-19 in Khartoum State, Sudan: An online-based cross-sectional study. Libyan Int Med Univ J [serial online] 2021 [cited 2022 Jan 28 ];6:19-26
Available from:

Full Text


Coronaviruses are a large group of RNA viruses that can transmit through birds and mammals, with humans being vulnerable to infection and transmission of coronavirus.[1],[2] Coronaviruses cause respiratory tract infections, which may be mild symptoms, such as common cold, in serious forms, can be lethal such as a novel coronavirus, which is a new strain that has not been previously reported in humans. The first report was in Wuhan, China, on December 31, 2019, then the outbreak was declared as a public health emergency on January 30, 2020; on February 11, 2020, the WHO announced a name for the new coronavirus disease, COVID-19.[3] Patients of this disease suffer from several symptoms such as fever, cough with or without sputum production, shortness of breath, headache, and loss of smell with or without loss of taste. Less common symptoms are sore throat, rhinorrhea, and GIT symptoms.[4],[5] There are two phenotypes that may occur: hypoxemia with relatively compliant lungs (typical viral pneumonitis), and acute respiratory distress syndrome. In addition, nonrespiratory symptoms regarding organ dysfunction may occur, such as renal failure, liver dysfunction, and cardiac dysrhythmia. Symptoms may be due to hyperinflammation syndrome (cytokine storm).[4]

Nowadays, there is a preventive vaccine for COVID-19, while there is no specific antiviral against it, regarding that, some studies suggested Remdesivir.[6] Regarding CDC recommendations, coronavirus is transmitted mainly from person to another by close contact (within 6 feet) with infected people through respiratory (e.g., coughs or sneezes) or transmitted by touching a surface or object that contaminated by the virus. The best prevention method is to avoid being exposed to the coronavirus by wearing face masks, washing hands with soap and water, and isolating confirmed and suspected cases.[7] On March 11, 2020, the WHO has declared that coronavirus disease-2019 (COVID-19) is a global pandemic infection.[3] Till June 13, 2020, the total number of confirmed cases in the world reached 7,553,182, and the death rate is 423,349, in Sudan, above 6879 cases were diagnosed, and above 433 cases died.[8]

Pharmacists provide essential medical services all over the world. In many communities, pharmacists may be the only health-care providers who accessible to patients in rural and far areas. Their practice sites include hospitals, clinics, physician offices, and community pharmacies that increase the risk of infection as coronavirus can sustain for a long time on various surfaces and stay on them from hour to days.[9],[10] Some studies showed that health-care workers (HCWs) lack knowledge and attitudes toward severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome.[11],[12] To our knowledge, there is no published data regarding the awareness of Sudanese pharmacists toward the COVID-19 outbreak, whereas pharmacists are an essential part of HCWs, therefore, it is necessary to assess their perspectives. Hence, this study aimed to assess the knowledge, attitude, and practice of Sudanese pharmacists regarding COVID-19.

 Materials and Methods

Study setting

This study was an online descriptive cross-sectional survey. It was conducted from April to June 2020 among the registered pharmacists in Khartoum state, Sudan. The pharmacists have been selected according to their registration and geographical distributions; they are distributed in different localities of Khartoum State.

Inclusion criteria

All registered pharmacists by the Federal Ministry of Health, in Khartoum State, were included in this study.

Sample size calculation

According to the list provided by the ministry of health, there were 2293 pharmacies in Khartoum state and the sample size was determined using the following equation:


N = Target population (number of pharmacies in Khartoum state)

n = size of the sample, e = margin of error.

n = 2293/[1 + 2293 (0.0025)], n = 343pharmacies.

Instead of taking 343 community pharmacists from 343 pharmacies within Khartoum state, we asked 350 community pharmacists from 350 pharmacies within Khartoum state to participate in the study accounting for any nonresponses or any missed data; but all of them were responded.

Sampling technique

An online link of the questionnaire was distributed to 350 community pharmacists randomly.

Data collection

The data was collected using an online questionnaire distributed for community pharmacists through “Google for.” A preliminary pilot study was conducted on 10 Pharmacists, and then, the questionnaire was reevaluated and standardized according to the respondents' responses. All ten questionnaires' results of the pilot study were excluded.

Questionnaire structure, variables, and interpretation

The edited questionnaire contains four parts as following nine questions for sociodemographic characteristics, eighteen questions for knowledge, five questions for attitude, and six questions for practice. Due to the lockdown process at the time of data collection, the questioner was entered in a Google Form and distributed to students through a link shared on social media.

Part A contained data about independent variables which include sociodemographic characteristics (age, gender, residence, level of education, the profession, years of experience, source of information regarding COVID-19, and whether they attending workshops or sessions regarding COVID-19).

Part B assessed the respondents' knowledge toward COVID-19 on 18 items, each correct answer for each knowledge's question was given one point, and the false answer and those who selected I do not know were given zero, then a score of knowledge for each participant was calculated, and the score median was taken as a cutoff point, and according to the value of the median of the scores (16 points), the participants were divided into two categories: those who have sufficient knowledge (whose knowledge score was ≥16) and those who have insufficient knowledge (whose knowledge score was <16).[13]

Part C assessed the respondents' attitude toward COVID-19 on 5 items. The items were rated on a 3-point Likert scale, that is, disagree – 0, neutral – 1, and agree – 2. The 5 Likert scale items were summed together to give a total score ranging from 0 to 10, in which a higher score reflects a more positive attitude. Then, the attitude' score was categorized as those having negative attitude (whose scores ranged 0–3), fair attitude (whose scores ranged 4–6), and positive attitude (whose scores ranged 7–10).[14]

Data analysis

Data were analyzed using the computerized program, Statistical Package for the Social Sciences, version 26 (IBM, SPSS, Illinois, Chicago, USA). The results were presented as tables. Chi-square test was used for cross-tabulation at 0.05 margins of error (P value). Descriptive statistics (frequency tables, median, histogram, means, and standard deviation [SD]) and inferential statistics (Chi-square test and logistic regression test) were performed.

Ethical consideration

Ethical approval was obtained from Omdurman Islamic University, faculty of pharmacy 3/2020. Research purpose and objectives were explained to participants in clear, simple words. Participants had the right to withdraw at any time without any deprivation. Privacy and confidentiality were kept.


Demographic characteristics of the participant

The participants' median age was 27 years, and 61.7% of them were between 23 and 28 years. Females were 65.7%. About 72.9% of the participants were bachelor degree holders and 73.1% were community pharmacists. The working experience for 54.4% of the participants was from 1 to 5 years. Nearly 41.79% of the participants depended on the Internet as the main source of information and 39.4%of them were depending on the WHO and scientific papers as the main source of information. About 78.6% of the participants reported that they did not attend workshops regarding COVID-19 [Table 1].{Table 1}

Knowledge regarding COVID-19

The median score of knowledge was 16 (out of 18) and 69.4% of the participants had sufficient knowledge, while 30.6% had insufficient knowledge. Almost 97.1% were well known that HCWs had a higher risk of being infected. About 89.1% knew that COVID-19 was fatal, while 83.7 knew that COVID-19 patients might present with diarrhea and GIT symptoms. On the other hand, 49.4% of the participants agreed that isolated people should not wear personal protective equipment (PPE). Finally, 73.1% of participants knew that antibiotics were not first-line treatment and the most effective treatment for all cases of COVID-19 [Table 2].{Table 2}

Attitude regarding COVID-19

The average score of attitude was 6.5 ± SD (1.8). About 27.1% of the participants reported a positive attitude, 62.6% reported a fair attitude, and only 10.3% reported a negative attitude. Nearly 63.4% of the participants agreed that COIVID-19 could be successfully controlled globally and 60.9% of them disagreed that their country could be able to control the pandemic situation soon. Almost 88.5% of the participants were agreed that most pharmacists could get the infection and may be a source of infection to their families. Eighty-three percent of them agreed that the prevalence of COVID-19 could be reduced by the active participation of most health-care providers in hospitals on infection control programs and 76.3%of them agreed with the idea of using developed vaccines available [Table 3].{Table 3}

Practice regarding COVID-19

About 68.3% of the participants reported that they keep 2 m between them others, and 88.3% of them were wearing facemask, gloves, and frequently use sensitizers. Nearly 47.7% of the participants stated that they would not dispense azithromycin without a prescription. Seventy percent of the participant did not visit any crowded place in recent few days. Seventy-one percent of them reported that frequently they wear masks when they left their homes. Forty-eight percent of the participants would give supportive therapy to the patients who complained of headaches, fever, and cough and were in close contact with COVID-19 patients [Table 4].{Table 4}

When the Chi-square test was performed, we found that knowledge was statistically significantly associated with gender (P = 0.001). On the other hand, attitude was statistically significantly associated with age and years of experience (P = 0.039, 0.01), respectively.

When the logistic regression test was performed, we found that gender was statistically significant with knowledge; females were more likely to have sufficient knowledge by two times than males (P = 0.002, confidence interval [CI] = 1.350–3.646). Interestingly, considering educational level, master holders were less likely to have sufficient knowledge than those with bachelor degree holders (P = 0.017, odd ratio = 0.467). This may be due to the uneven number of master degree holders compared with bachelor degree participants. Clinical pharmacists were more likely to have sufficient knowledge by two times than those who work in the manufacturing companies (CI = 0.439–10.239). Similarly, those who had work experience for 6–10 years were more likely to have sufficient knowledge by twofolds than those whose work experience was less than a year (CI = 0.734–5.698). On the other hand, those who perform protective measures against the coronavirus were more likely to have sufficient knowledge by 1.6 times than those who do not (CI = 0.515–4.756) [Table 5].{Table 5}


On March 13, the first confirmed case of COVID-19 has been announced in Sudan. Since that time, the health authorities have planned many strategies to control and manage this critical threat. HCWs are the main part of these implementing strategies, and they represent the frontline in this fight against COVID-19. Pharmacists are the most important HCWs, as they play a critical role in the management cycle of coronavirus outbreak.[15],[16] Besides, after applying the lockdown rule in Sudan, pharmacies one of the few places that are allowed to be open for providing services to the community. Due to that, community pharmacists have become the first accessed point for seeking medical advice.[16],[17],[18] Furthermore, many published reports have highlighted the role of pharmacists in the prevention of COVID-19 spreading.[19],[20] Thus, pharmacists should have adequate knowledge and a positive attitude toward all aspects related to COVID-19, particularly to clinical symptoms, prevention strategies, and proposed treatments. To the best of our knowledge, this is the first study to assess the knowledge, attitudes, and practice of pharmacists toward COVID-19 in Sudan.

In the current cross-sectional study, 350 Sudanese pharmacists were enrolled in this survey. Females were the higher participant (65.7%) because the girls represent the larger proportions in Sudanese pharmacy schools in recent years. As the community pharmacy field in Sudan is the main site for job opportunities, particularly for bachelor degree holders, therefore, 73.1% of the participants were community pharmacists.[21] Furthermore, 54.5% of the pharmacists have experience of 1–5 years; this may because most of the fresh-graduated pharmacists start working in community pharmacies before seeking other jobs.[22],[23] Attending scientific workshops and webinars about COVID-19 helped a lot to increase the knowledge about control and prevention from the disease in a proper manner, as there are many misleading and unverified information found in the social media.[24] However, globally, social media is still considered the primary source of information about COVID-19, even for health-care professionals.[25] In the current study, the Internet represents the main source of information (to 41.8% of the participant), 39.4% of them were right to depend on WHO and scientific papers as the main source of information; nevertheless, 21.4% of the participants reported that they attend workshops regarding COVID-19. These findings were consistent with previous studies from Pakistan, Turkey, China, Iran, and Uganda.[25],[26],[27],[28],[29]

In general, knowledge is important to provide positive attitudes and behaviors, appropriate practice toward prevention, and control of any diseases, including COVID-19.[30] The knowledge of Sudanese pharmacists about COVID-19 was evaluated in this study and showed that 69.4% of them have sufficient knowledge. This overall knowledge score was in line with the knowledge score of community pharmacists in Pakistan (71.5%).[31] However, most of Turkey pharmacists (90%) reported having adequate knowledge about COVID-19.[27] This may due to the appearance of the disease in Sudan was late in comparison to other countries. Interestingly, female students were showed to have more knowledge about COVID-19 than males (P = 0.001). This might be attributed to higher care and curiosity behaviors for females than males. Similar findings were observed in Chinese and Indian reports.[32],[33] Fascinatingly, many published studies indicated that pharmacists have the highest knowledge about the COVID-19 among other healthcare professionals, such as physicians and nurses.[25],[26] These observations further support the role of pharmacists in controlling the COVID-19 outbreak.

Based on the results, the majority of pharmacists responded well to the knowledge questions related to the severity of the disease, transmission ways of the virus, and the COVID-19 symptoms. However, around 75% of pharmacists knew about the possibility of transmitting the virus from COVID-19 dead person. The elderly patients are more prone to be infected and additionally more likely to be affected by the COVID-19 complications.[34] Here, 91.7% of pharmacists were considered elderly are the most vulnerable group that can be infected easily by the virus. The majority of them agreed with the importance of preventing infection to adults and children. Furthermore, to prevent the transmission of the disease, the WHO and the Ministry of Health recommended the following precautionary measures such as using disinfectants and wearing face masks in public places.[35],[36] In line with this, we found that the majority of the pharmacists believed that such preventive measures reduce the transmission of the disease. Moreover, isolation of the suspected case is another critical step in controlling the transmission,[37] which was acknowledged by most participants. However, around half of them indicated that isolated patients should wear PPE. On the other hand, to prevent the development of antimicrobial resistance, antibiotics should not be used for prevention or treating the COVID-19.[36],[38] Nonetheless, 27% of pharmacists have deemed that taking antibiotics as a preventive measure against COVID-19. Thus, to improve the knowledge and perception, further training and education on transmission, symptoms, and management about COVID-19 are required in our population.

Increased knowledge about the disease has a higher impact on the gain of positive attitudes toward a health crisis such as the COVID-19 outbreak.[39] Due to the comparatively low level of knowledge in the current study, most Sudanese pharmacists (62.2%) showed fair attitudes toward the disease. In contrast, other studies revealed that most health-care professionals have a positive attitude toward COVID-19.[24],[25],[39] Around 63% of the participants agreed that COVID-19 would be successfully controlled globally. Although the Sudanese government has applied many rules to control the spreading of the disease, such as lockdown and prohibiting the gathering and increasing public awareness by disseminating information about COVID-19 and the preventive guides toward the disease, only 26.6% agreed that Sudan would be able to win the battle against the disease. Furthermore, 83% of the pharmacists believed in the involvement of all health-care providers in infection control programs to reduce the prevalence of COVID-19. Today, research institutes and pharmaceutical companies have developed a promising and effective vaccine to counteract this outbreak.[40],[41] In this study, 76.3% of the pharmacists thought positively about developing the vaccine in the near future.

Regarding the practice of Sudanese pharmacists, our study indicated that most of the pharmacists had good practice to avoid SARS-CoV-2. Keeping a distance of 2 m will help in reducing the transmission of the disease; interestingly, we found that around 68% of pharmacists are using a barrier in the area of working to keep this distance. Moreover, the highest good practice was observed in wearing face masks and gloves and frequent use of sensitizers at the workplace. These findings were also observed in Pakistanis community pharmacists,[31] and contrast to another study that reported only 8.9% of the hospital pharmacists are using facemasks at the workplace.[27] Azithromycin was reported to have efficacy against COVID-19; in this study, 47.7% of the participants stated that they would not dispense azithromycin without a prescription, whereas 48% of the participants would give supportive therapy to the patients who were complaining of headache, fever, and cough and were with close contact with COVID-19 patient. Therefore, it is crucial to improve the pharmacists' knowledge and attitude regarding the COVID-19 infection that will ultimately be translated into proper practice.

The current study has some notable limitations. First, the cross-sectional design may not allow for determining the relationship between the outcomes and other factors. In additon, the study was conducted in only Khartoum state, so the findings cannot be generalized to all pharmacists in the country. Second, we used an online-based survey method to prevent infection exposure, and as the users of social platforms are mostly young people, this resulted in a large proportion of young participants. Therefore, the possibility of selection bias should be considered. Thus, further research will still need to potentially include longitudinal tracking of the factors contributing to the COVID-19 morbidity and mortality rather than pharmacists' awareness.


More than two-third of the participants have sufficient knowledge regarding COVID-19. Only one-tenth of them have a negative attitude, and their practice toward the disease was relatively good. Chi-square test revealed that knowledge was statistically significantly associated with gender. On the other hand, the attitude was statistically significantly associated with age and years of experience.


We do appreciate all participants for their voluntary participation in this study.

Funding information


Conflict of interest statement

The authors report no conflicts of interest.



1Lim YX, Ng YL, Tam JP, Liu DX. Human coronaviruses: A review of virus-host interactions. Diseases 2016;4:26.
2Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virol J 2019;16:69.
3WHO Director-General's Opening Remarks at the Media Briefing on COVID-19-11 March 2020. Available from: briefing-on-covid-19---11-march-2020. [Last accessed on 2020 May 25].
4Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol 2020;277:1-11.
5Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – An update on the status. Mil Med Res 2020;7:11.
6Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the treatment of Covid-19 – Preliminary report. Reply. N Engl J Med 2020;383:994.
7Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): How to Protest Yourself & Others. Available from: [Last accessed on 2020 Jun 12].
8Organization WH. WHO Coronavirus Disease (COVID 19) Dashboard. Geneva, Switzerland: World Health Organization; 2020. Available from: https://covid19who int/. [Last accessed on 2020 Jun 02].
9International Pharmaceutical Federation (FIP). Covid-19: Guidelines for Pharmacists and the Pharmacy Workforce. Updated 26 March 2020. Available from: [Last accessed on 2020 Jun 05].
10Suman R, Javaid M, Haleem A, Vaishya R, Bahl S, Nandan D. Sustainability of coronavirus on different surfaces. J Clin Exp Hepat 2020;10:386-90.
11Deng JF, Olowokure B, Kaydos-Daniels SC, Chang HJ, Barwick RS, Lee ML, et al. Severe acute respiratory syndrome (SARS): Knowledge, attitudes, practices and sources of information among physicians answering a SARS fever hotline service. Public Health 2006;120:15-9.
12Alsahafi AJ, Cheng AC. Knowledge, attitudes and behaviours of healthcare workers in the kingdom of Saudi Arabia to MERS coronavirus and other emerging infectious diseases. Int J Environ Res Public Health 2016;13:1214.
13Ali-Risasi C, Mulumba P, Verdonck K, Vanden Broeck D, Praet M. Knowledge, attitude and practice about cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of Congo. BMC Womens Health 2014;14:30.
14Yong CC, Islahudin F, Shah NM. Knowledge, attitude and perception of parents on the use of cough and cold medications in children. Southeast Asian J Trop Med Public Health 2015;46:512-25.
15Basheti IA, Nassar R, Barakat M, Alqudah R, Abufarha R, Mukattash TL, et al. Pharmacists' readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles. Res Social Adm Pharm. 2021;17:514-22.
16Dawoud D. Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists. Res Social Adm Pharm 2020;13:011.
17Ung CO. Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm 2020;16:583-6.
18Khan Z, Muhammad K, Ahmed A, Rahman H. Coronavirus outbreaks: Prevention and management recommendations. Drugs Ther Perspect 2020;36:1-3.
19Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm. 2021;17:1813-8.
20Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract 2020;13:8.
21Ibrahim A, Scott J. Community pharmacists in Khartoum State, Sudan: Their current roles and perspectives on pharmaceutical care implementation. Int J Clin Pharm 2013;35:236-43.
22Ibrahim M, Badi S, Yousef B. Knowledge and practice of community pharmacists toward dispensing of cough medications for children Khartoum State: A cross-sectional study. Intern J Health Allied Sci 2020;9:147-52.
23Mohamed SS, Mahmoud AA, Ali AA. The role of Sudanese community pharmacists in patients' self-care. Int J Clin Pharm 2014;36:412-9.
24Bhagavathula AS, Aldhaleei WA, Rahmani J, Mahabadi MA, Bandari DK. Knowledge and Perceptions of COVID-19 Among Health Care Workers: Cross-Sectional Study. JMIR Public Health Surveill. 2020;6:19160.
25Huynh G, Nguyen TN, Vo KN, Pham LA. Knowledge and attitude toward COVID-19 among healthcare workers at District 2 Hospital, Ho Chi Minh City. Asian Pac J Trop Med 2020;13:260.
26Saqlain M, Munir MM, Rehman SU, Gulzar A, Naz S, Ahmed Z, et al. Knowledge, attitude, practice and perceived barriers among healthcare workers regarding COVID-19: A cross-sectional survey from Pakistan. J Hosp Infect 2020;105:419-23.
27Kara E, Demİrkan K, Ünal S. Knowledge and Attitudes Among Hospital Pharmacists About COVID-19. Turk J Pharm Sci. 2020;17:242-8.
28Olum R, Chekwech G, Wekha G, Nassozi DR, Bongomin F. Coronavirus disease 2019: Knowledge, attitude, and practices of health care workers at Makerere University Teaching Hospitals, Uganda. Front Public Health 2020;8:181.
29Olum R, Chekwech G, Wekha G, Nassozi DR, Bongomin F. Coronavirus disease-2019: Knowledge, attitude, and practices of health care workers at Makerere University Teaching Hospitals, Uganda. Front Public Health 2020;8:181.
30McEachan R, Taylor N, Harrison R, Lawton R, Gardner P, Conner M. Meta-analysis of the Reasoned Action Approach (RAA) to understanding health behaviors. Ann Behav Med 2016;50:592-612.
31Zhong BL, Luo W, Li HM, Zhang QQ, Liu XG, Li WT, et al. Knowledge, attitudes, and practices towards COVID 19 among Chinese residents during the rapid rise period of the COVID 19 outbreak: A quick online cross sectional survey. Int J Biol Sci 2020;16:1745-52.
32Zhong BL, Luo W, Li HM, Zhang QQ, Liu XG, Li WT, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: A quick online cross-sectional survey. Int J Biol Sci 2020;16:1745-52.
33Modi PD, Nair G, Uppe A, Modi J, Tuppekar B, Gharpure AS, et al. COVID-19 awareness among healthcare students and professionals in Mumbai metropolitan region: A questionnaire-based survey. Cureus 2020;12:e7514.
34Lorusso A, Calistri P, Petrini A, Savini G, Decaro N. Novel coronavirus (SARS-CoV-2) epidemic: A veterinary perspective. Vet Ital 2020;56:5-10.
35Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-6.
36Xiao Y, Torok ME. Taking the right measures to control COVID-19. Lancet Infect Dis 2020;20:523-4.
37Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020;87:281-6.
38Shi Y, Wang J, Yang Y, Wang Z, Wang G, Hashimoto K, et al. Knowledge and attitudes of medical staf in Chinese psychiatric hospitals regarding COVID 19. Brain Behav Immun Health 2020;4:100064.
39Peng Y, Pei C, Zheng Y, Wang J, Zhang K, Zheng Z, et al. A cross-sectional survey of knowledge, attitude and practice associated with COVID-19 among undergraduate students in China. BMC Public Health. 2020;20:1292.
40Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med 2020;382:1969-73.
41Le TT, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020;19:305-6.